Bristol Myers Squibb Co is a general drug manufacturer company located in New York, United States, which is part of the Healthcare sector, and is traded under the ticker BMY on the NYSE exchange.
Bristol Myers Squibb Co stock last closed at $59.21, up 0.03% from the previous day, and has increased 12.67% in one year. It has overperformed other stocks in the Drug Manufacturers - General industry by 0.1 percentage points. Bristol Myers Squibb Co stock is currently +50.47% from its 52-week low of $39.35, and -6.51% from its 52-week high of $63.33.
As of Mar 26, 2025, there are 2.03B BMY shares outstanding. The market value of BMY is $120.16B. In the last 24 hours, 11.54M BMY shares were traded.
How to Buy Bristol Myers Squibb Co Stock
Not sure how to invest in Bristol Myers Squibb Co stock? Here's how.
Decide where to buy Bristol Myers Squibb Co stock: You need to pick a stock brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you determine where to buy Bristol Myers Squibb Co stock.
Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
Put funds into your brokerage account: Select your payment method and add your details.
Evaluate Bristol Myers Squibb Co stock: The Bristol Myers Squibb Co ticker symbol is BMY. Is Bristol Myers Squibb Co stock a good investment? Should you buy shares of BMY? How do BMY's underlying business fundamentals look? Do top analysts think Bristol Myers Squibb Co is a good buy? Why has BMY's stock price moved recently? (Hint: Our stock research tools can help you decide if BMY is a good stock to buy).
Execute your BMY trade: Decide if you will purchase BMY shares at the current market price or use a limit order to purchase BMY shares at a specific price.
Keep tabs on your investment in BMY: Create a watchlist to the latest updates on your position in Bristol Myers Squibb Co stock.
Step 1: Decide where to buy Bristol Myers Squibb Co stock
You will need an online brokerage account in order to access the NYSE market and buy BMY stock.
A brokerage account is an investment account that enables you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
We believe that eToro is the best online stock brokerage. eToro gives you:
You can invest in stocks with 0% commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to global financial markets: From Technology to Healthcare, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by creating an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create a brokerage account
Now that you've chosen your brokerage, you'll need to fill out some personal details so you are able to invest in BMY stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Bristol Myers Squibb Co stock
Once you have decided on the best place to buy Bristol Myers Squibb Co stock, it's crucial to evaluate their stock prior to investing, so you can understand the risk as well as the upside.
Bristol Myers Squibb Co Metrics
BMY Price
$59.21
1w %
-1.45%
1y %
12.67%
5y %
13.32%
P/E
-13.43x
P/B
7.36x
P/S
2.49x
PEG
N/A
Revenue
$48.30B
Earnings
-$8.95B
Fore. Rev. Growth
-4.29%
Fore. Earn. Growth
N/A
Market Cap
$120.16B
Next Earnings
Apr 25, 2025
Next Dividend
N/A
Bristol Myers Squibb Co Due Diligence Checks
WallStreetZen was built to help part-time investors perform more in-depth fundamental analysis quickly.
You can see all of the due diligence checks on BMY's stock page.
Is BMY stock overvalued?
Analysts use many financial metrics, analyses, models, and charts to gauge BMY's fair value.
Using relative valuations ratios:
BMY may be overvalued based on its P/B ratio of 7.36x, relative to Drug Manufacturers - General industry P/B ratio of 6.37x
There are more short-term assets than short-term liabilities on the BMY balance sheet.
BMY's operating cash flow of $15.19B allows it to safely service it's debt of $49.65B.
Negative Financial Indicators:
BMY earnings of -$8.39B is not enough to cover its interest payments.
BMY profit margin has gone down from 17.8% to -18.5% in the past year.
Total BMY debt is higher than 5 years ago, relative to shareholder equity.
BMY has a relatively high debt to equity ratio of 4.67.
There are more long-term liabilities than short-term assets on the BMY balance sheet.
Do analysts think it's a good time to buy BMY stock
Out of 12 sell side analysts who give recommendations on BMY, the consensus analyst rating on Bristol Myers Squibb Co is a Hold
Please note that analyst ratings are not recommendations, nor are they financial advice.
Most Recent BMY Analyst Upgrades/Downgrades
Tim Anderson, a top 33% analyst from Bank of America reinstates BMY with a hold rating and announces their BMY price target of $63.00, on Dec 10, 2024.
Evan Seigerman, a bottom 22% analyst from BMO Capital maintains BMY with a hold rating and raises their BMY price target from $57.00 to $61.00, on Nov 12, 2024.
Terence Flynn, a top 9% analyst from Morgan Stanley maintains BMY with a strong sell rating and raises their BMY price target from $36.00 to $39.00, on Nov 12, 2024.
David Risinger, a top 7% analyst from Leerink Partners upgrades BMY to a buy rating and raises their BMY price target from $55.00 to $73.00, on Nov 12, 2024.
An analyst from Bernstein initiates coverage on BMY with a hold rating and announces their BMY price target of $56.00, on Oct 17, 2024.
Last year, BMY revenue was $48.30B. During the last 5 year, BMY's revenue has increased by 13.06% per year. This was faster than the Drug Manufacturers - General industry average of 9.18%.
No, Bristol Myers Squibb Co doesn't provide an income stream by paying out dividends.
Get opinions from other investors
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Execute your BMY trade
There are two primary types of orders:
Market order: A market order is an order to buy or sell a security at the best available price. Market orders are usually fine.
Limit order: A limit order enables you to buy or sell a security at a specific price (or better). If you want to be certain you're buying or selling at a specific dollar amount, use a limit order.
Click the Open button and your broker will place the order.
If you require more assistance investing in stocks on eToro, watch the helpful video below:
How much does it cost to buy one Bristol Myers Squibb Co share?
As of Mar 26, 2025, it costs $59.21 to buy one share of Bristol Myers Squibb Co stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.169 shares of BMY.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.